BCAN Announces 2016 Young Investigator Awardees

June 22, 2016
by Stephanie Chisolm

The Bladder Cancer Advocacy Network (BCAN) has announced the recipients of the 2016 Young Investigator Awards. The Young Investigator Awards fund researchers in basic, translational, clinical, epidemiologic, bio-engineering or any other scientific or research field. Recipients must be working in a research environment capable of supporting transformational bladder cancer research. The Stephen Hale Gushée Young Investigator Award will support Kent William Mouw, M.D., Ph.D. of Dana-Farber Cancer Institute, for his research “Identifying Genomic Determinants of Chemoradiotherapy Response in Muscle-Invasive Bladder Cancer.” Dr. Mouw’s study will leverage new genomic techniques to better understand how these biomarkers can benefit muscle invasive bladder cancer…


Press Release: FDA Approves New Bladder Cancer Treatment

May 18, 2016
by Andrea Maddox-Smith

The Bladder Cancer Advocacy Network (BCAN) applauds the U.S. Food and Drug Administration (FDA) approval of an innovative, first-of-its-kind bladder cancer treatment, establishing a brand new class of therapy for the disease. Genentech, a member of the Roche Group, produced this new treatment, TECENTRIQ™ (atezolizumab), which allows the body’s immune system to work more effectively to fight cancer.



January 11, 2016
by Stephanie Chisolm

BCAN just returned from the American Society of Clinical Oncology’s 2016 Genitourinary Cancer Symposium held January 7-9 in San Francisco.


2015: A Moment of Reflection

December 22, 2015
by Diane Quale

As we reflect back on 2015–BCAN’s 10th anniversary year–we should all be very proud of what we have accomplished. We have created a vibrant community of survivors, co-survivors, family, friends, and medical professionals who are giving bladder cancer a voice and improving the lives of all who are impacted by this disease.


Did you know October 15 – December 7 is Medicare Open Enrollment for 2016 Coverage?

October 15, 2015
by Stephanie Chisolm

Medicare is a health insurance program for: people age 65 or older, people under age 65 with certain disabilities, and people of all ages with End-Stage Renal Disease (permanent kidney failure requiring dialysis or a kidney transplant). Your health needs may change from one year to the next. Your health plan may also change its benefits and costs each year too. Medicare Open Enrollment (October 15–December 7) is the time when all people with Medicare are encouraged to review their current health and prescription drug coverage. This review includes checking on any changes in costs, coverage, and benefits that will…


Press Release – BCAN Launches Bladder Cancer Genomics Consortium

September 24, 2015
by Monica Smith

The Bladder Cancer Advocacy Network (BCAN) and Paradigm today announced a partnership for the launch of a large-scale genomically-driven bladder cancer study. This prospective study is the first project of the Bladder Cancer Genomics Consortium (BCGC), a collaborative effort between BCAN and major medical centers.